Osteomel Once Weekly (Alendronic Acid)

Alendronic acid, the active ingredient in Osteomel Once Weekly, is a bisphosphonate presented as a tablet for oral use. It is used to treat osteoporosis and other bone loss conditions in post‑menopausal women and men at risk of fracture.

GNH USA supplies Osteomel Once Weekly as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Osteomel Once Weekly is a bisphosphonate that acts on bone metabolism to reduce fracture risk. - Osteoporosis: helps reduce the incidence of vertebral and hip fractures in post‑menopausal women and men with osteoporosis. - Osteopenia: slows bone mineral density loss in patients with low bone mass. - Paget’s disease of bone: decreases abnormal bone turnover associated with the disease.

Adverse reactions to Osteomel Once Weekly are generally mild to moderate and reflect its impact on the gastrointestinal tract and calcium metabolism.

Common Side Effects: - Upper upper upper ... -  ... ... ... ... ... ... ... ... - … … … … ... ... ... ... ... - … ... ... … ... ... ... … ... - … ... … … .... ... ... ... ...  - … ... … ... ... ... ... ... ...

Serious or Rare  ....   t  ....   ewline   ewline  .

...